8-K: Privia Health Reports Strong Q1 2026 Results

Privia Health Group, Inc. announced robust first quarter 2026 financial results, exceeding expectations with significant growth in revenue and key operating metrics, while reiterating full-year guidance.

Summary

• Privia Health Group, Inc. reported strong financial results for the first quarter ended March 31, 2026.
• Total revenue increased by 25.8% to $603.8 million compared to $480.1 million in the first quarter of 2025.
• Gross profit rose by 21.2% to $125.6 million.
• Operating income saw a substantial increase of 42.2% to $7.4 million.
• Net income decreased by 27.4% to $3.1 million, impacted by a significant increase in non-cash stock compensation expense.
• Non-GAAP adjusted net income grew by 22.3% to $24.3 million.
• Key operating metrics showed strong performance: Implemented Providers increased by 13.6% to 5,535, and Value-Based Care Attributed Lives grew by 26.5% to 1,606,000.
• The company reiterated its full-year 2026 guidance for most metrics and raised its guidance for Attributed Lives.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue and operating metric growth, and reiterated/raised guidance, despite a dip in GAAP net income due to non-cash expenses.

Positives

• Total revenue increased by 25.8% to $603.8 million in Q1 2026.
• Operating income grew by 42.2% to $7.4 million.
• Non-GAAP adjusted net income increased by 22.3% to $24.3 million.
• Implemented Providers grew by 13.6% to 5,535.
• Value-Based Care Attributed Lives increased by 26.5% to 1,606,000.
• Practice Collections increased by 14.6% to $914.8 million.
• Adjusted EBITDA saw a significant increase of 36.3% to $36.7 million.
• Full-year 2026 guidance for most metrics was reiterated, and Attributed Lives guidance was raised.

Negatives

• Net income decreased by 27.4% to $3.1 million in Q1 2026 compared to $4.2 million in Q1 2025.
• Net income per share decreased by 33.3% to $0.02.
• Non-cash stock compensation expense increased from $17.8 million in Q1 2025 to $21.9 million in Q1 2026.

Risks

• The heavily regulated industry in which the company operates and potential non-compliance with healthcare laws.
• Complexity of legal frameworks governing relationships with Medical Groups and providers.
• Execution of growth strategy may not prove viable or yield expected results.
• Difficulties in timely implementation of the proprietary technology solution.
• High level of competition in the industry.
• Challenges in establishing presence in new geographic markets.
• Potential impact of failures or service disruptions from key third-party vendors.
• Potential decreases in reimbursement rates and challenges in negotiating favorable payer contracts.

Future Outlook

Privia Health maintained its full-year 2026 outlook for most metrics, including Implemented Providers, Practice Collections, GAAP Revenue, Care Margin, Platform Contribution, and Adjusted EBITDA. The company raised its guidance range for Attributed Lives to 1,600,000 - 1,625,000. Approximately 80% of Adjusted EBITDA is expected to convert to free cash flow in full-year 2026. Guidance does not assume any new business development activity.

Management Comments

• The company reported 'Continued strength in same-store growth and new provider additions'.
• The reiterated and raised guidance reflects 'Continued Momentum'.

Industry Context

StockSavvy.ai notes that Privia Health's Q1 2026 results demonstrate continued expansion in value-based care arrangements and physician network growth, aligning with broader industry trends towards more integrated and outcome-focused healthcare delivery models.

Stakeholder Impact

• Shareholders: Positive impact from strong revenue growth, operating income, and Adjusted EBITDA, with reiterated and raised full-year guidance.
• Providers: Continued network expansion and value-based care attribution suggest ongoing support and potential for increased value-based payments.
• Patients: Growth in attributed lives and focus on value-based care indicate a continued emphasis on improved health outcomes and potentially lower costs.

Next Steps

• Company will host a conference call on May 7, 2026, at 8:00 am ET to discuss results and outlook.
• Webcast will be archived on the Privia Health Investor Relations website.

Key Dates

Recommendation

The company delivered strong operational and revenue growth, with positive trends in key metrics and reiterated/raised guidance. However, the decrease in GAAP net income due to increased stock compensation and the inherent risks in the healthcare sector warrant a 'hold' recommendation pending further analysis of long-term profitability and execution.

Keywords

Privia Health, 8-K, Q1 2026 Earnings, Financial Results, Healthcare, Physician Enablement, Value-Based Care, Adjusted EBITDA